What is 23ANDME HOLDING CO A's earnings per share (EPS)?

23ANDME HOLDING CO A (MEHCQ) reported diluted earnings per share of -$10.88 for fiscal year 2025. This represents a 61.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

23ANDME HOLDING CO A (MEHCQ) Financials

MEHCQ

Trailing 12 months to June 30, 2025

Revenue $174.9M -12.2% YoY

Net Income -$235.3M +62.7% YoY

EPS (Diluted) -$8.98 +50.0% YoY

Free Cash Flow -$155.9M -11.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Jun 30, 2025 Reported Aug 4, 2025 Currency USD FYE March

Newest figures come from the 10-K for Q1 FY2026, filed Aug 4, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MEHCQ SEC filings page.

23ANDME HOLDING CO A (MEHCQ) reported $174.9M in revenue over the twelve months to Jun 30, 2025, down 12.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MEHCQ FY2025 2026-08-30

Shrinking revenue now coexists with higher gross margins, but operating losses and financing pressure still dominate the model

Gross margin reached 52.7% in FY2025 as revenue fell 13.5% from FY2024; this points to a cost or revenue-mix shift rather than scale-driven growth. The improvement did not translate into profitability because the operating margin remained deeply negative, showing that overhead and development spending still absorb the gross profit.

Operating cash flow was -$169.6M while free cash flow was -$170.5M; their near match means accounting losses are closely reflected in cash usage. With capital expenditures of only $869K, the cash demand is primarily operational rather than a reinvestment cycle.

Assets dropped from $395.2M in FY2024 to $159.9M in FY2025, while liabilities exceeded assets in FY2025, leaving negative equity and less balance-sheet cushion. The current ratio reached 1.4x, while reported liquidity equaled 2.7 months of the latest annual operating outflow, indicating tighter short-term flexibility.

Financial Health Signals

Financial health score not available

23ANDME HOLDING CO A does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-24.73

23ANDME HOLDING CO A scores -24.73, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($96.4M) relative to total liabilities ($186.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/7

23ANDME HOLDING CO A passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

23ANDME HOLDING CO A reported a net loss of $280.9M while operations used $169.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$25.4M

YoY-37.1%

QoQ-43.7%

23ANDME HOLDING CO A generated $25.4M in revenue in Q1 2026. This represents a decrease of 37.1% from the same quarter a year earlier. Against the prior quarter it is down 43.7%.

EBITDA

-$28.5M

YoY+46.8%

QoQ+65.6%

23ANDME HOLDING CO A's EBITDA was -$28.5M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 46.8% from the same quarter a year earlier. Against the prior quarter it is up 65.6%.

Net Income

-$23.8M

YoY+65.7%

QoQ+76.0%

23ANDME HOLDING CO A reported -$23.8M in net income in Q1 2026. This represents an increase of 65.7% from the same quarter a year earlier. Against the prior quarter it is up 76.0%.

EPS (Diluted)

-$0.87

YoY+68.9%

QoQ+77.0%

23ANDME HOLDING CO A earned -$0.87 per diluted share (EPS) in Q1 2026. This represents an increase of 68.9% from the same quarter a year earlier. Against the prior quarter it is up 77.0%.

Cash & Balance Sheet

Free Cash Flow

-$29.0M

YoY+33.5%

QoQ+29.0%

23ANDME HOLDING CO A recorded an outflow of $29.0M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents an increase of 33.5% from the same quarter a year earlier. Against the prior quarter it is up 29.0%.

Cash & Debt

$39.8M

YoY-76.6%

QoQ+4.1%

5Y CAGR-26.1%

23ANDME HOLDING CO A held $39.8M in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

Diluted avg 27M

23ANDME HOLDING CO A had a weighted average of 27M diluted shares in Q1 2026; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

53.2%

YoY+2.8pp

QoQ+14.7pp

23ANDME HOLDING CO A's gross margin was 53.2% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 2.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.7 percentage points.

Net Margin

-93.7%

23ANDME HOLDING CO A's net profit margin was -93.7% in Q1 2026, showing the share of revenue converted to profit. No change is given against Q1 2025: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Operating Margin

Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q1 2026.

Capital Allocation

R&D Spending

$14.5M

YoY-51.3%

QoQ+35.8%

23ANDME HOLDING CO A invested $14.5M in research and development in Q1 2026. This represents a decrease of 51.3% from the same quarter a year earlier. Against the prior quarter it is up 35.8%.

Capital Expenditures

$42K

YoY-88.5%

QoQ-72.9%

5Y CAGR-58.8%

23ANDME HOLDING CO A invested $42K in capex in Q1 2026, funding long-term assets and infrastructure. This represents a decrease of 88.5% from the same quarter a year earlier. Against the prior quarter it is down 72.9%.

Share Buybacks

Not reported for Q1 2026.

MEHCQ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MEHCQ quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Revenue	$174.9M	$189.9M-13.5%	$219.6M-26.7%	$299.5M+10.1%	$271.9M+11.5%	$243.9M-20.1%	$305.5M
Cost of Revenue	$81.8M	$89.9M-26.2%	$121.7M-27.2%	$167.2M+20.3%	$138.9M+9.5%	$126.9M-24.5%	$168.0M
Gross Profit	$93.2M	$100.0M+2.2%	$97.9M-26.0%	$132.3M-0.5%	$132.9M+13.6%	$117.0M-14.9%	$137.4M
R&D Expenses	$86.3M	$101.6M-3.3%	$105.0M-9.5%	$116.0M-38.8%	$189.4M+18.5%	$159.9M-11.8%	$181.3M
SG&A Expenses	$104.0M	$113.3M-13.8%	$131.4M+11.3%	$118.1M+21.2%	$97.4M-1.8%	$99.1M+66.9%	$59.4M
Operating Income	-$213.8M	-$240.6M+58.6%	-$581.7M-160.8%	-$223.1M+12.2%	-$254.2M-37.2%	-$185.2M+28.3%	-$258.4M
EBITDA	N/A	-$226.3M+59.5%	-$558.5M-192.4%	-$191.0M+17.1%	-$230.5M-37.9%	-$167.1M+29.2%	-$236.2M
Interest Expense	N/A	N/A	$14.3M+48.1%	$9.7M+3393.1%	$277K+8.6%	$255K-95.9%	$6.2M
Income Tax	-$41K	-$41K-156.2%	$73K+102.6%	-$2.8M+20.3%	-$3.5M	$0	$0
Net Income	-$235.3M	-$280.9M+57.9%	-$666.7M-113.9%	-$311.7M-43.3%	-$217.5M-18.4%	-$183.6M+26.8%	-$250.9M
EPS (Basic)	N/A	-$10.88+61.2%	-$28.01-103.0%	-$13.80-2200.0%	-$0.60+67.4%	-$1.84	N/A
EPS (Diluted)	-$8.98	-$10.88+61.2%	-$28.01-103.0%	-$13.80	-$0.60	-$1.84	N/A
Diluted Shares (Avg)	N/A	26M+8.5%	24M+5.4%	23M	362M	100M	N/A

Metric	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$25.4M-37.1%	$45.1M-29.5%	$60.3M+34.7%	$44.1M-11.9%	$40.4M-33.6%	$64.0M-30.7%	$44.7M-33.2%	$50.0M-33.9%
Cost of Revenue	$11.9M-40.6%	$27.8M-27.4%	$20.4M-18.5%	$21.7M-23.4%	$20.0M-33.6%	$38.2M-30.0%	$25.1M-30.7%	$28.3M-24.4%
Gross Profit	$13.5M-33.6%	$17.4M-32.6%	$39.8M+102.3%	$22.4M+3.1%	$20.4M-33.6%	$25.8M-31.7%	$19.7M-36.0%	$21.7M-43.2%
R&D Expenses	$14.5M-51.3%	$10.6M-70.3%	$20.2M-15.4%	$41.0M-24.8%	$29.7M-52.4%	-$35.8M-22.0%	$23.9M-58.3%	$54.6M+3.8%
SG&A Expenses	$23.3M-28.4%	$30.4M+28.8%	$26.9M-15.4%	$23.4M-7.4%	$32.6M-35.8%	$23.6M-18.2%	$31.8M+3.5%	$25.3M-12.4%
Operating Income	-$30.7M+46.6%	-$86.1M+34.0%	-$35.9M+86.4%	-$61.2M+22.7%	-$57.5M+47.4%	-$130.4M-511.7%	-$262.9M-170.8%	-$79.1M-16.3%
EBITDA	-$28.5M+46.8%	-$82.8M+34.1%	-$32.9M+87.3%	-$57.2M+21.0%	-$53.5M+47.7%	-$125.5M-423.7%	-$258.2M-190.5%	-$72.3M-21.3%
Interest Expense	N/A	N/A	N/A	$2.0M-46.5%	$2.6M-40.2%	$3.0M-30.4%	$3.2M-12.0%	$3.8M+169.5%
Income Tax	$0	$0-100.0%	$0-100.0%	-$41K-213.9%	$0	$18K+101.6%	$19K+103.1%	$36K+102.8%
Net Income	-$23.8M+65.7%	-$99.4M+52.4%	-$53.0M+80.9%	-$59.1M+21.5%	-$69.4M+33.7%	-$208.8M-225.8%	-$278.0M-202.3%	-$75.3M-13.9%
EPS (Basic)	-$0.87+68.9%	-$3.78-779.1%	-$2.01+82.6%	-$2.32+26.8%	-$2.80-1117.4%	-$0.43-207.1%	-$11.56-5680.0%	-$3.17-2013.3%
EPS (Diluted)	-$0.87+68.9%	-$3.78	-$2.01+82.6%	-$2.32+26.8%	-$2.80	-$0.43-207.1%	-$11.56	-$3.17
Diluted Shares (Avg)	27M+10.9%	N/A	26M+9.6%	26M+7.5%	25M	N/A	24M	24M

MEHCQ Balance Sheet

MEHCQ quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Total Assets	$159.9M-59.5%	$395.2M-58.1%	$942.6M-18.2%	$1.2B+154.8%	$452.1M	N/A
Current Assets	$102.7M-59.8%	$255.3M-39.9%	$425.0M-29.4%	$601.8M+91.9%	$313.6M	N/A
Cash & Equivalents	$38.2M-82.3%	$216.5M-44.0%	$386.8M-30.1%	$553.2M+95.8%	$282.5M+1129856.0%	$25K
Short-Term Investments	$0	$0	$0	$0	$0	$0
Inventory	$15.6M+24.8%	$12.5M+21.6%	$10.2M-5.0%	$10.8M+72.9%	$6.2M	N/A
Accounts Receivable	$1.4M-59.3%	$3.3M+75.2%	$1.9M-43.9%	$3.4M+36.2%	$2.5M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0
Goodwill	N/A	$0-100.0%	$351.7M0.0%	$351.7M	$0	N/A
Total Liabilities	$186.6M-9.7%	$206.6M-9.6%	$228.7M-3.3%	$236.4M-77.4%	$1.0B	N/A
Current Liabilities	$72.7M-42.9%	$127.3M-14.8%	$149.4M-2.5%	$153.2M+26.0%	$121.6M	N/A
Non-Current Liabilities	$113.9M+43.6%	$79.3M+0.1%	$79.2M-4.7%	$83.2M-91.0%	$926.1M	N/A
Total Equity	-$26.7M-114.2%	$188.5M-73.6%	$713.9M-22.0%	$915.7M+253.7%	-$595.6M+4.1%	-$620.9M
Retained Earnings	-$2.5B-12.9%	-$2.2B-44.3%	-$1.5B-26.1%	-$1.2B-22.3%	-$977.2M	N/A

Metric	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$144.3M-60.8%	$159.9M-59.5%	$277.4M-54.4%	$318.9M-60.2%	$368.0M-57.8%	$395.2M-58.1%	$608.2M-40.6%	$801.2M-23.0%
Current Assets	$90.0M-61.4%	$102.7M-59.8%	$161.6M-47.9%	$188.8M-36.6%	$233.0M-35.3%	$255.3M-39.9%	$310.0M-39.1%	$298.0M-41.1%
Cash & Equivalents	$39.8M-76.6%	$38.2M-82.3%	$79.3M-67.3%	$126.6M-50.6%	$170.0M-45.9%	$216.5M-44.0%	$242.4M-44.0%	$256.4M-37.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$13.4M-9.0%	$15.6M+24.8%	$21.4M+36.6%	$14.8M-0.9%	$14.7M+24.8%	$12.5M+21.6%	$15.7M+31.0%	$15.0M+8.5%
Accounts Receivable	$1.2M+11.6%	$1.4M-59.3%	$10.1M-44.5%	$446K-70.3%	$1.1M-73.4%	$3.3M+75.2%	$18.2M-32.3%	$1.5M-97.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$152.9M-56.5%	$351.7M0.0%
Total Liabilities	$187.2M-16.6%	$186.6M-9.7%	$214.7M-7.1%	$217.0M+23.3%	$224.5M+14.7%	$206.6M-9.6%	$231.0M-15.6%	$176.0M-20.5%
Current Liabilities	$111.4M-27.1%	$72.7M-42.9%	$153.3M+6.4%	$152.8M+50.4%	$152.9M+28.5%	$127.3M-14.8%	$144.1M-28.0%	$101.6M-29.9%
Non-Current Liabilities	$75.8M+5.8%	$113.9M+43.6%	$61.4M-29.4%	$64.2M-13.7%	$71.7M-6.7%	$79.3M+0.1%	$86.9M+18.1%	$74.4M-2.8%
Total Equity	-$42.9M-129.9%	-$26.7M-114.2%	$62.7M-83.4%	$101.9M-83.7%	$143.5M-78.8%	$188.5M-73.6%	$377.2M-49.8%	$625.3M-23.7%
Retained Earnings	-$2.5B-10.5%	-$2.5B-12.9%	-$2.4B-19.9%	-$2.3B-36.5%	-$2.2B-39.2%	-$2.2B-44.3%	-$2.0B-36.2%	-$1.7B-24.9%

Not reported in any period shown, so not listed: Long-Term Debt.

MEHCQ Cash Flow Statement

MEHCQ quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Operating Cash Flow	-$155.3M	-$169.6M-3.2%	-$164.3M+0.6%	-$165.4M+0.9%	-$166.8M-124.7%	-$74.3M+60.0%	-$185.8M
Depreciation & Amortization	N/A	$14.3M-38.4%	$23.2M-27.6%	$32.1M+35.3%	$23.7M+31.1%	$18.1M-18.7%	$22.2M
Stock-Based Compensation	N/A	$62.0M-48.4%	$120.2M+3.6%	$116.0M+100.3%	$57.9M-34.5%	$88.4M+97.2%	$44.8M
Capital Expenditures	$545K	$869K-23.0%	$1.1M-72.1%	$4.0M+2.0%	$4.0M-2.1%	$4.1M-94.1%	$68.4M
Free Cash Flow	-$155.9M	-$170.5M-3.0%	-$165.4M+2.4%	-$169.4M+0.8%	-$170.8M-118.1%	-$78.3M+69.2%	-$254.1M
Investing Cash Flow	-$3.6M	-$3.7M+61.5%	-$9.6M+14.9%	-$11.3M+89.5%	-$108.1M-1554.5%	-$6.5M+91.0%	-$72.8M
Financing Cash Flow	$24.0M	-$279K-107.8%	$3.6M-63.3%	$9.8M-98.2%	$546.0M+251.5%	$155.3M+1659.2%	$8.8M

Metric	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$29.0M+33.0%	-$40.7M-58.0%	-$44.7M-270.2%	-$40.9M+28.3%	-$43.3M+37.6%	-$25.8M+42.7%	-$12.1M-147.2%	-$57.1M+21.7%
Depreciation & Amortization	$2.2M-44.3%	$2.9M-27.5%	$3.0M-36.2%	$4.0M-41.2%	$4.0M-41.9%	$4.1M-43.3%	$4.7M-42.7%	$6.8M-19.0%
Stock-Based Compensation	$5.7M-73.5%	N/A	$9.2M-64.9%	$19.5M-17.9%	$21.6M-57.8%	N/A	$26.4M-23.2%	$23.7M-18.0%
Capital Expenditures	$42K-88.5%	$155K-44.4%	$148K+9.6%	$200K-32.4%	$366K-12.6%	$279K-76.6%	$135K-85.1%	$296K-10.6%
Free Cash Flow	-$29.0M+33.5%	-$40.9M-56.9%	-$44.8M-267.3%	-$41.1M+28.4%	-$43.6M+37.5%	-$26.1M+43.5%	-$12.2M-149.5%	-$57.4M+21.6%
Investing Cash Flow	-$1.0M+10.6%	-$734K+65.8%	$887K+144.1%	-$2.7M+2.6%	-$1.2M+57.1%	-$2.1M+34.7%	-$2.0M+34.4%	-$2.8M-35.2%
Financing Cash Flow	$24.3M+269711.1%	-$529K-126.4%	-$19K-118.1%	$260K-83.7%	$9K+107.9%	$2.0M-23.3%	$105K+1054.5%	$1.6M-71.8%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

MEHCQ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MEHCQ quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K
Gross Margin	52.7%+8.1pp	44.6%+0.4pp	44.2%-4.7pp	48.9%+0.9pp	48.0%+3.0pp	45.0%
Operating Margin	-126.7%	-264.8%	-74.5%+19.0pp	-93.5%-17.6pp	-75.9%+8.7pp	-84.6%
Net Margin	-147.9%	-303.5%	-104.1%	-80.0%-4.7pp	-75.3%+6.9pp	-82.1%
Return on Equity	N/A	-353.7%-310.0pp	-43.6%-19.9pp	-23.8%	N/A	N/A
Return on Assets	-175.7%-7.0pp	-168.7%-135.7pp	-33.1%-14.2pp	-18.9%+21.7pp	-40.6%	N/A
Current Ratio	1.41-0.6x	2.01-0.8x	2.84-1.1x	3.93+1.3x	2.58	N/A
Debt-to-Equity	N/A	1.10+0.8x	0.32+0.1x	0.26	N/A	N/A
Asset Turnover	1.19+0.6x	0.56+0.2x	0.32+0.1x	0.24-0.3x	0.54	N/A
FCF Margin	-89.8%-14.4pp	-75.3%-18.8pp	-56.6%+6.2pp	-62.8%-30.7pp	-32.1%+51.1pp	-83.2%

Metric	Q1'2610-K	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	53.2%+2.8pp	38.5%-1.8pp	66.1%+22.1pp	50.8%+7.4pp	50.4%0.0pp	40.3%-0.6pp	44.0%-1.9pp	43.5%-7.1pp
Operating Margin	-120.8%	-190.7%	-59.5%	-138.8%	-142.3%	-203.6%	-587.6%	-158.3%
Net Margin	-93.7%	-220.0%	-88.0%	-134.1%	-171.7%	-326.1%	-621.2%	-150.5%
Return on Equity	N/A	N/A	-84.6%-10.9pp	-58.0%-45.9pp	-48.4%-32.9pp	-110.8%-101.8pp	-73.7%-61.5pp	-12.0%-4.0pp
Return on Assets	-16.5%+2.3pp	-62.1%-9.3pp	-19.1%+26.6pp	-18.5%-9.1pp	-18.9%-6.8pp	-52.8%-46.0pp	-45.7%-36.7pp	-9.4%-3.0pp
Current Ratio	0.81-0.7x	1.41-0.6x	1.05-1.1x	1.24-1.7x	1.52-1.5x	2.01-0.8x	2.15-0.4x	2.93-0.6x
Debt-to-Equity	N/A	N/A	3.42+2.8x	2.13+1.8x	1.56+1.3x	1.10+0.8x	0.61+0.2x	0.280.0x
Asset Turnover	0.18+0.1x	0.28+0.1x	0.22+0.1x	0.14+0.1x	0.110.0x	0.16+0.1x	0.070.0x	0.060.0x
FCF Margin	-114.2%	-90.6%-49.8pp	-74.4%-47.1pp	-93.3%	-108.0%	-40.7%+9.2pp	-27.3%-64.1pp	-114.8%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$26.7M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
23ANDME HOLDING CO A MEHCQ	FY2025	$189.9M	-$280.9M	N/A	$96.4M	—
ENZO BIOCHEM INC ENZB	FY2024	$31.9M	-$26.1M	-81.7%	$36.6M	—

Where 23ANDME HOLDING CO A Ranks

Frequently Asked Questions

What is 23ANDME HOLDING CO A's annual revenue?

23ANDME HOLDING CO A (MEHCQ) reported $189.9M in total revenue for fiscal year 2025. This represents a -13.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is 23ANDME HOLDING CO A's revenue growing?

23ANDME HOLDING CO A (MEHCQ) revenue declined by 13.5% year-over-year, from $219.6M to $189.9M in fiscal year 2025.

Is 23ANDME HOLDING CO A profitable?

No, 23ANDME HOLDING CO A (MEHCQ) reported a net income of -$280.9M in fiscal year 2025.

What is 23ANDME HOLDING CO A's EBITDA?

23ANDME HOLDING CO A (MEHCQ) had EBITDA of -$226.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is 23ANDME HOLDING CO A's gross margin?

23ANDME HOLDING CO A (MEHCQ) had a gross margin of 52.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is 23ANDME HOLDING CO A's free cash flow?

23ANDME HOLDING CO A (MEHCQ) recorded an outflow of $170.5M in free cash flow during fiscal year 2025. This represents a -3.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is 23ANDME HOLDING CO A's operating cash flow?

23ANDME HOLDING CO A (MEHCQ) recorded an outflow of $169.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are 23ANDME HOLDING CO A's total assets?

23ANDME HOLDING CO A (MEHCQ) had $159.9M in total assets as of fiscal year 2025, including both current and long-term assets.

What are 23ANDME HOLDING CO A's capital expenditures?

23ANDME HOLDING CO A (MEHCQ) invested $869K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does 23ANDME HOLDING CO A spend on research and development?

23ANDME HOLDING CO A (MEHCQ) invested $101.6M in research and development during fiscal year 2025.

What is 23ANDME HOLDING CO A's current ratio?

23ANDME HOLDING CO A (MEHCQ) had a current ratio of 1.41 as of fiscal year 2025, which is considered adequate.

What is 23ANDME HOLDING CO A's return on assets (ROA)?

23ANDME HOLDING CO A (MEHCQ) had a return on assets of -175.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does 23ANDME HOLDING CO A's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, 23ANDME HOLDING CO A (MEHCQ) held $38.2M in cash, cash equivalents and investments, and reported an operating cash outflow of $169.6M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is 23ANDME HOLDING CO A's debt-to-equity ratio negative or not reported?

23ANDME HOLDING CO A (MEHCQ) has negative shareholder equity of -$26.7M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is 23ANDME HOLDING CO A's Altman Z-Score?

23ANDME HOLDING CO A (MEHCQ) has an Altman Z-Score of -24.73, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is 23ANDME HOLDING CO A's Piotroski F-Score?

23ANDME HOLDING CO A (MEHCQ) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are 23ANDME HOLDING CO A's earnings high quality?

23ANDME HOLDING CO A (MEHCQ) reported a net loss of $280.9M while operations used $169.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.